9 Meters Biopharma Inc (NMTR)

1.3300
0.0000(0.00%)
  • Volume:
    740,866
  • Bid/Ask:
    1.3300/1.3400
  • Day's Range:
    1.3250 - 1.3500

NMTR Overview

Prev. Close
1.33
Day's Range
1.325-1.35
Revenue
-
Open
1.34
52 wk Range
0.63-2.25
EPS
-0.15
Volume
740,866
Market Cap
338.82M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,992,186
P/E Ratio
-
Beta
-3.97
1-Year Change
72.77%
Shares Outstanding
254,753,151
Next Earnings Date
Nov 16, 2021
What is your sentiment on 9 Meters Biopharma Inc?
or
Vote to see community's results!

9 Meters Biopharma Inc News

9 Meters Biopharma Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyBuy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyBuy

9 Meters Biopharma Inc Company Profile

9 Meters Biopharma Inc Company Profile

Employees
12

9 Meters Biopharma, Inc., formerly Innovate Biopharmaceuticals, Inc., is a gastrointestinal platform company. The Company is focused on developing treatments for patients with rare disorders and unmet needs. Its pipeline includes drug candidates for short bowel syndrome and celiac disease. Its pipeline includes NM-002, Larazotide, NM-003 and NM-004. NM-002 is a long-acting injectable GLP-1 analogue for short bowel syndrome (SBS). Larazotide is an orally administered, gut-restricted tight-junction regulator for celiac disease. NM-003 is a GLP-2 analogue, under orphan indication selection. NM -004 is an immunomodulator, granted pediatric orphan designation in ulcerative colitis.

Read More
  • Lot of insister buy. Buy and stand
    0
    • Why is this rising? Its good but why?
      0
      • Why this big pressure on this stock???? We are waiting from 2 $
        0
        • No revenue, no profit for few quarters, I would not be hopeful!
          0
      • insider buying continue
        0
        • Buy buy buy
          0
          • Good time to buy here
            0
            • Phase 2 buy now-->
              0
              • buy nownews on therapy
                1
                • is worth to inv?
                  0
                  • Yes. 4$ target.
                    2
                • Great mid-to-long term accumulate on the stock.  If you use 4-8 week time frames you should use Options, oh and a technical pattern reader.
                  0
                  • WTH is going on? why is this stock down 13.46% its ***me!
                    0
                    • Investor news> https://twitter.com/newsfilterio/status/1359992842823868419
                      0
                      • This stock can go to 20-30$ in a few years, if they will got approval from the FDA.
                        0
                        • So you do encourage to buy this stock now ??
                          0
                        • Ali Hasan with your own risk.
                          0
                      • Super Happy with this Stock Perf over +175.99% any other stocks with this high growth recommended? That cost less than $1
                        0
                        • Check out this green energy stock with thicker SNPW... Huge potential trust me!
                          1
                      • amazing! what is going on here?
                        0
                        • Target 5
                          0
                      • Raleigh based @9metersbio currently has a drug called Larazotide in Phase III trials showing promising results fighting Celiac Disease. However researchers also believe the drug is showing promise with #COVID19 patients. PT =6 by Oppenheimer...
                        0
                        • it's going to 20$.
                          0
                          • why?
                            0
                        • today 2$
                          2
                          • isn't this going bellow 1 be very bad?
                            0
                            • Maybe on the technical pattern, However, this is a Bio Play with potential approval from FDA that technical patterns can NOT predict.
                              0
                          • FYI Bearish Pennant on 1/21/21 target  $.75. However, on 1/22/21 LT Bullish target $3.40.  I am Own it and buy Calls. If it goes below $1.00 -.75 buy it with both hands.
                            0
                            • Will hit at least 5usd before the end of the month
                              1
                              • Why?
                                0
                              • Because I said so
                                7
                              • well it didnt
                                0
                            • A lot knuckleheads here saying hold hold hold, but not giving any reason or context. Useless microwave traders. Smdh
                              1
                              • Holddddd
                                0
                                • Bought @ 0.72 should I hold / sell? How far up can it Go?
                                  0
                                  • dont sell
                                    0
                                  • Depends how much u invested If less that 10k its not much But if u bought oner 10k when it was 72 meqns u almost doubled
                                    0
                                • What's a good price to buy in and to Sell out?
                                  0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.